Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Lilly completes acquisition of Centessa

PRIVATEAug 05, 2026•4 days ago

Acquiring Company

Lilly

Acquired Company

Centessa

BostonBiotechnologyHealth CareBiotechnologyHealth Care

Description

Lilly has successfully completed its acquisition of Centessa, enhancing its portfolio in the biotechnology sector. This strategic move follows Lilly's announcement of a robust second quarter, reflecting significant revenue growth. The acquisition aims to consolidate Lilly's position in developing innovative medicines for serious diseases.

Company Information

Company

Lilly

About

Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter and LinkedIn. C-LLY

Predictive Intelligence

Strategic

ML-powered predictions for Lilly's next move

Learn about Strategic plan

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Centessa?

Centessa was acquired by Lilly. The deal was reported on August 5, 2026. Lilly unites caring with discovery to create medicines that make life better for people around the world. Lilly is privately held and operates in Biotechnology.

When did Lilly acquire Centessa?

Lilly's acquisition of Centessa was reported on August 5, 2026. Lilly has successfully completed its acquisition of Centessa, enhancing its portfolio in the biotechnology sector. This strategic move follows Lilly's announcement of a robust second quarter, reflecting significant revenue growth. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Centessa do?

Centessa is a biotechnology company dedicated to developing novel therapies for various health conditions, particularly those related to impaired wakefulness. It is privately held, operating in Biotechnology, and is based in Boston.